Aglaya Iyevleva

8PUBLICATIONS
32CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 30, 2025
Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas.

Aglaya G Iyevleva, Svetlana N Aleksakhina, Anna P Sokolenko

|Aug 28, 2025
Interconnection of Gut Microbiome and Efficacy of Immune Checkpoint Inhibitors in Inoperable Non-Small-Cell Lung Cancer.

Fedor Moiseenko, Andrey Kechin, Maksim Koryukov

|Jun 13, 2025
Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.

Tatyana N Sokolova, Grigory A Yanus, Svetlana N Aleksakhina

|Sep 28, 2023
Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples.

Aleksandr A Romanko, Rimma S Mulkidjan, Vladislav I Tiurin

|Mar 24, 2022
Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.

Natalia V Mitiushkina, Alexandr A Romanko, Elena V Preobrazhenskaya

|Jan 12, 2022
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.

Aglaya G Iyevleva, Svetlana N Aleksakhina, Anna P Sokolenko

Pageof 2

Frequent Collaborators

3 joint publications

Evgeny N Imyanitov

2 joint publications

Natalia V Mitiushkina

2 joint publications

Ekaterina S Kuligina

1 joint publications

Aleksandr A Romanko